Granules India, 532482, GRANULES Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,350.78
29.46
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

15,143.46
0.25%
4.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.30
11.64
6.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.16
10.26
3.47

PAT CAGR (%)

10 Years
5 Years
3 Years

16.12
5.51
-0.61

P:E (Median)

8 Years
5 Years
3 Years

16.99
17.16
18.20

P:BV (Average)

8 Years
5 Years
3 Years

2.98
3.36
3.18

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.99
11.43
11.67

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 16.73 21.76 27.5 33.63
P/E Ratio 34.84 26.78 21.2 17.33
Revenue 3755 4711 5409 6116
EBITDA 856 1016 1219 1453
Net Income 405 528 668 814
ROA 9.2
P/Bk Ratio 4.37 3.81 3.27 2.81
ROE 13.38 14.54 15.74 16.92
FCFF -41.06 309.44 245.95 330.47
FCFF Yield -0.27 2.02 1.6 2.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 567.99 1,009.41 -43.73% 851.95 821.00 3.77% 940.19 1,013.88 -7.27% 984.49 1,032.39 -4.64%
Expenses 465.39 800.99 -41.90% 674.54 664.23 1.55% 750.91 796.58 -5.73% 737.60 793.77 -7.08%
EBITDA 102.60 208.42 -50.77% 177.41 156.77 13.17% 189.28 217.30 -12.89% 246.88 238.62 3.46%
EBIDTM 18.06% 20.65% 20.82% 19.10% 20.13% 21.43% 25.08% 23.11%
Other Income 2.78 1.25 122.40% 1.81 0.44 311.36% 3.42 2.56 33.59% 0.67 -0.93 -
Interest 14.56 17.65 -17.51% 17.52 14.79 18.46% 19.79 14.12 40.16% 19.78 11.76 68.20%
Depreciation 34.75 36.01 -3.50% 35.85 35.27 1.64% 36.41 37.77 -3.60% 36.16 38.32 -5.64%
PBT 56.07 156.01 -64.06% 125.86 107.16 17.45% 136.51 167.97 -18.73% 191.61 187.61 2.13%
Tax 14.68 39.86 -63.17% 32.08 27.31 17.47% 39.30 42.68 -7.92% 48.91 47.81 2.30%
PAT 41.39 116.16 -64.37% 93.78 79.84 17.46% 97.22 125.29 -22.40% 142.70 139.80 2.07%
PATM 7.29% 11.51% 11.01% 9.72% 10.34% 12.36% 14.50% 13.54%
EPS 1.71 4.79 -64.30% 3.87 3.29 17.63% 4.01 5.17 -22.44% 5.89 5.77 2.08%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 966.62 1,189.49 -18.74% 1,179.87 985.52 19.72% 1,175.78 1,195.50 -1.65% 1,155.58 1,146.13 0.82%
Expenses 763.30 976.51 -21.83% 920.60 848.69 8.47% 920.08 967.38 -4.89% 905.10 914.83 -1.06%
EBITDA 203.32 212.97 -4.53% 259.27 136.82 89.50% 255.70 228.12 12.09% 250.48 231.29 8.30%
EBIDTM 21.03% 17.90% 21.97% 13.88% 21.75% 19.08% 21.68% 20.18%
Other Income 3.25 1.53 112.42% 2.06 0.35 488.57% 1.87 3.38 -44.67% 0.65 0.95 -31.58%
Interest 25.67 25.96 -1.12% 27.02 22.46 20.30% 28.76 18.80 52.98% 28.65 16.97 68.83%
Depreciation 52.52 52.52 0.00% 52.87 49.24 7.37% 53.18 48.71 9.18% 52.39 48.36 8.33%
PBT 128.38 136.02 -5.62% 181.44 65.47 177.13% 175.64 163.99 7.10% 170.09 166.90 1.91%
Tax 31.15 33.91 -8.14% 46.79 17.58 166.15% 45.99 44.38 3.63% 44.44 42.57 4.39%
PAT 97.23 102.12 -4.79% 134.65 47.89 181.17% 129.65 119.60 8.40% 125.65 124.33 1.06%
PATM 10.06% 8.58% 11.41% 4.86% 11.03% 10.00% 10.87% 10.85%
EPS 4.01 4.21 -4.75% 5.56 1.98 180.81% 5.35 4.94 8.30% 5.18 5.14 0.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,344.62 3,755.09 3,931.20 3,238.44 3,134.98 2,309.93 2,098.43 1,646.64 1,349.48 1,327.74 1,213.31 Net Sales Growth -13.72% -4.48% 21.39% 3.30% 35.72% 10.08% 27.44% 22.02% 1.64% 9.43% Cost Of Goods Sold 1,542.70 1,906.91 2,161.45 1,757.75 1,509.64 1,221.98 1,250.31 903.09 658.58 729.65 707.21 Gross Profit 1,801.92 1,848.17 1,769.75 1,480.69 1,625.34 1,087.94 848.11 743.55 690.90 598.09 506.10 GP Margin 53.88% 49.22% 45.02% 45.72% 51.85% 47.10% 40.42% 45.16% 51.20% 45.05% 41.71% Total Expenditure 2,628.44 2,953.73 3,095.91 2,594.40 2,273.61 1,815.79 1,766.08 1,353.12 1,053.68 1,058.15 1,003.53 Power & Fuel Cost - 93.01 88.94 69.91 65.51 57.00 54.94 48.22 38.67 34.97 36.32 % Of Sales - 2.48% 2.26% 2.16% 2.09% 2.47% 2.62% 2.93% 2.87% 2.63% 2.99% Employee Cost - 332.99 278.19 247.86 234.36 192.51 167.00 147.92 125.81 106.34 89.23 % Of Sales - 8.87% 7.08% 7.65% 7.48% 8.33% 7.96% 8.98% 9.32% 8.01% 7.35% Manufacturing Exp. - 270.58 205.25 221.01 167.94 138.10 118.49 103.97 82.92 64.50 45.62 % Of Sales - 7.21% 5.22% 6.82% 5.36% 5.98% 5.65% 6.31% 6.14% 4.86% 3.76% General & Admin Exp. - 133.95 125.56 91.19 139.16 94.21 74.55 65.30 58.05 54.46 53.52 % Of Sales - 3.57% 3.19% 2.82% 4.44% 4.08% 3.55% 3.97% 4.30% 4.10% 4.41% Selling & Distn. Exp. - 166.59 206.74 173.76 124.16 88.95 81.21 76.49 74.78 63.44 69.40 % Of Sales - 4.44% 5.26% 5.37% 3.96% 3.85% 3.87% 4.65% 5.54% 4.78% 5.72% Miscellaneous Exp. - 49.69 29.78 32.92 32.83 23.03 19.57 8.13 14.88 4.80 69.40 % Of Sales - 1.32% 0.76% 1.02% 1.05% 1.00% 0.93% 0.49% 1.10% 0.36% 0.18% EBITDA 716.17 801.36 835.29 644.04 861.37 494.14 332.35 293.52 295.80 269.59 209.78 EBITDA Margin 21.41% 21.34% 21.25% 19.89% 27.48% 21.39% 15.84% 17.83% 21.92% 20.30% 17.29% Other Income 8.68 5.78 12.88 18.12 13.72 26.46 28.49 23.77 14.52 6.67 2.96 Interest 71.65 72.00 38.67 16.35 23.77 26.86 28.36 32.93 32.16 37.05 30.93 Depreciation 143.17 143.85 145.56 126.16 118.45 101.82 90.77 75.92 71.35 58.25 49.56 PBT 510.05 591.29 663.94 519.65 732.87 391.91 241.71 208.45 206.80 180.96 132.26 Tax 134.97 155.37 165.16 133.13 180.09 108.96 79.87 69.29 63.98 60.18 37.03 Tax Rate 26.46% 26.28% 24.88% 25.62% 24.57% 19.70% 33.04% 33.24% 30.94% 33.26% 28.00% PAT 375.09 435.92 498.79 386.52 552.78 444.07 161.84 139.16 142.83 120.78 95.23 PAT before Minority Interest 375.09 435.92 498.79 386.52 552.78 444.07 161.84 139.16 142.83 120.78 95.23 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.21% 11.61% 12.69% 11.94% 17.63% 19.22% 7.71% 8.45% 10.58% 9.10% 7.85% PAT Growth -18.65% -12.60% 29.05% -30.08% 24.48% 174.39% 16.30% -2.57% 18.26% 26.83% EPS 15.47 17.98 20.58 15.95 22.80 18.32 6.68 5.74 5.89 4.98 3.93

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,477.85 4,506.37 4,511.92 3,764.92 3,237.54 2,598.65 2,279.20 1,684.62 1,410.57 1,357.18 1,292.92 Net Sales Growth -0.86% -0.12% 19.84% 16.29% 24.59% 14.02% 35.29% 19.43% 3.93% 4.97% Cost Of Goods Sold 1,818.59 2,021.25 2,307.28 1,883.64 1,391.28 1,280.93 1,255.56 896.32 679.63 725.03 746.95 Gross Profit 2,659.26 2,485.12 2,204.63 1,881.28 1,846.27 1,317.72 1,023.64 788.30 730.93 632.15 545.97 GP Margin 59.39% 55.15% 48.86% 49.97% 57.03% 50.71% 44.91% 46.79% 51.82% 46.58% 42.23% Total Expenditure 3,509.08 3,650.39 3,598.60 3,043.30 2,382.31 2,073.33 1,895.16 1,406.20 1,111.73 1,081.29 1,084.31 Power & Fuel Cost - 100.64 95.69 74.66 68.85 59.74 57.67 48.22 38.67 34.97 45.73 % Of Sales - 2.23% 2.12% 1.98% 2.13% 2.30% 2.53% 2.86% 2.74% 2.58% 3.54% Employee Cost - 550.24 420.35 366.44 324.29 259.04 209.82 165.21 140.19 117.57 106.96 % Of Sales - 12.21% 9.32% 9.73% 10.02% 9.97% 9.21% 9.81% 9.94% 8.66% 8.27% Manufacturing Exp. - 408.01 273.93 298.74 228.39 177.94 157.62 120.84 88.60 66.97 50.89 % Of Sales - 9.05% 6.07% 7.93% 7.05% 6.85% 6.92% 7.17% 6.28% 4.93% 3.94% General & Admin Exp. - 211.99 187.96 134.41 172.28 125.63 99.96 83.05 67.65 60.38 59.84 % Of Sales - 4.70% 4.17% 3.57% 5.32% 4.83% 4.39% 4.93% 4.80% 4.45% 4.63% Selling & Distn. Exp. - 290.63 280.00 247.45 159.80 112.17 91.84 83.08 81.37 67.75 71.70 % Of Sales - 6.45% 6.21% 6.57% 4.94% 4.32% 4.03% 4.93% 5.77% 4.99% 5.55% Miscellaneous Exp. - 67.62 33.38 37.96 37.42 57.88 22.69 9.49 15.61 8.62 71.70 % Of Sales - 1.50% 0.74% 1.01% 1.16% 2.23% 1.00% 0.56% 1.11% 0.64% 0.17% EBITDA 968.77 855.98 913.32 721.62 855.23 525.32 384.04 278.42 298.84 275.89 208.61 EBITDA Margin 21.63% 18.99% 20.24% 19.17% 26.42% 20.22% 16.85% 16.53% 21.19% 20.33% 16.13% Other Income 7.83 4.40 14.29 18.22 26.88 36.56 26.68 10.84 9.93 5.62 4.34 Interest 110.10 105.82 55.93 23.21 26.28 27.02 28.46 33.06 32.26 37.07 32.35 Depreciation 210.96 207.33 184.49 158.63 151.46 136.95 105.48 76.20 71.51 58.40 52.65 PBT 655.55 547.23 687.17 558.00 704.36 397.90 276.78 180.00 204.99 186.03 127.96 Tax 168.37 141.92 170.58 145.24 154.91 115.73 89.11 63.40 65.20 61.15 37.05 Tax Rate 25.68% 25.93% 24.82% 26.03% 21.99% 27.19% 32.20% 35.22% 31.81% 32.87% 28.95% PAT 487.18 405.31 516.60 412.76 549.46 309.91 187.67 116.60 139.79 124.89 90.91 PAT before Minority Interest 487.18 405.31 516.60 412.76 549.46 309.91 187.67 116.60 139.79 124.89 90.91 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.88% 8.99% 11.45% 10.96% 16.97% 11.93% 8.23% 6.92% 9.91% 9.20% 7.03% PAT Growth 23.67% -21.54% 25.16% -24.88% 77.30% 65.14% 60.95% -16.59% 11.93% 37.38% EPS 20.10 16.72 21.31 17.03 22.67 12.79 7.74 4.81 5.77 5.15 3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,110.95 2,699.46 2,530.66 2,162.62 1,811.59 1,423.24 1,278.20 884.36 664.50 425.41 Share Capital 24.24 24.20 24.80 24.77 25.42 25.42 25.38 22.87 21.67 20.43 Total Reserves 3,073.00 2,661.83 2,493.62 2,127.56 1,777.38 1,391.01 1,247.40 859.04 614.03 404.98 Non-Current Liabilities 126.13 210.04 300.36 391.88 487.14 558.30 503.65 195.52 252.93 299.92 Secured Loans 50.01 148.64 233.70 333.81 414.83 478.78 433.13 123.90 183.66 242.05 Unsecured Loans 0.00 0.00 0.00 0.00 6.08 0.00 0.00 0.34 0.55 0.62 Long Term Provisions 37.86 29.26 28.31 24.84 21.50 12.58 7.70 7.25 5.58 3.97 Current Liabilities 1,768.55 1,593.77 1,541.60 1,128.33 847.45 842.84 856.95 775.09 650.46 381.39 Trade Payables 654.63 744.39 606.80 507.65 322.88 276.89 260.54 209.90 177.15 183.24 Other Current Liabilities 193.63 162.67 180.39 183.49 143.48 106.55 62.90 89.76 78.87 69.84 Short Term Borrowings 904.23 663.08 720.04 409.27 371.69 454.21 525.10 473.83 392.85 114.87 Short Term Provisions 16.06 23.63 34.37 27.92 9.41 5.20 8.41 1.60 1.58 13.45 Total Liabilities 5,005.63 4,503.27 4,372.62 3,682.83 3,146.18 2,824.38 2,638.80 1,854.97 1,567.89 1,106.72 Net Block 1,323.67 1,329.80 1,170.83 985.00 926.88 699.95 660.15 605.58 523.29 522.17 Gross Block 2,312.27 2,200.71 1,949.12 1,693.02 1,522.83 1,195.01 1,065.65 937.36 784.53 725.69 Accumulated Depreciation 988.60 870.91 778.29 708.02 595.94 495.06 405.50 331.78 261.24 203.53 Non Current Assets 2,371.70 2,185.30 2,041.97 1,804.97 1,671.30 1,615.46 1,460.30 1,021.47 747.81 631.99 Capital Work in Progress 52.94 63.46 210.52 164.01 129.78 333.03 286.03 132.31 35.28 18.50 Non Current Investment 941.40 676.53 596.53 591.53 445.39 506.46 75.12 75.11 88.95 72.47 Long Term Loans & Adv. 53.70 115.52 64.08 64.42 169.24 76.02 439.00 208.47 100.30 18.70 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 Current Assets 2,633.92 2,317.97 2,330.65 1,877.87 1,474.88 1,208.91 1,178.50 833.50 820.08 473.05 Current Investments 0.00 0.00 0.00 0.00 109.85 0.00 0.00 0.00 0.00 0.00 Inventories 578.62 593.41 590.74 461.70 343.95 314.14 227.36 237.59 210.13 179.40 Sundry Debtors 1,633.19 1,372.19 1,210.43 1,014.24 627.00 704.21 692.91 468.31 444.16 194.09 Cash & Bank 228.11 202.98 355.09 241.23 272.34 62.44 97.41 39.36 110.70 52.23 Other Current Assets 194.01 36.47 54.19 48.15 121.74 128.13 160.82 88.23 55.09 47.33 Short Term Loans & Adv. 157.26 112.91 120.21 112.56 81.37 92.25 113.52 49.24 45.75 1.78 Net Current Assets 865.37 724.20 789.06 749.53 627.43 366.07 321.55 58.40 169.63 91.66 Total Assets 5,005.62 4,503.27 4,372.62 3,682.84 3,146.18 2,824.37 2,638.80 1,854.97 1,567.89 1,106.73

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,225.54 2,834.91 2,586.54 2,173.27 1,843.72 1,529.47 1,304.18 903.60 661.60 431.16 Share Capital 24.24 24.20 24.80 24.77 25.42 25.42 25.38 22.87 21.67 20.43 Total Reserves 3,183.00 2,792.68 2,545.01 2,126.23 1,800.02 1,493.09 1,273.38 878.28 611.13 410.74 Non-Current Liabilities 176.04 254.73 282.83 366.30 485.98 552.63 488.19 187.99 246.62 356.52 Secured Loans 68.97 148.64 233.70 333.81 414.83 478.78 433.13 123.90 183.66 302.59 Unsecured Loans 0.00 0.00 0.00 0.00 6.69 0.00 0.00 0.34 0.55 0.62 Long Term Provisions 37.88 29.26 28.31 24.84 21.50 12.58 7.70 7.25 5.58 4.03 Current Liabilities 2,082.29 1,813.50 1,641.60 1,173.10 893.40 896.48 877.91 787.13 654.75 415.03 Trade Payables 749.53 782.13 638.61 541.05 356.88 323.48 274.35 215.98 181.10 187.63 Other Current Liabilities 261.08 193.19 200.85 194.25 153.16 113.60 69.84 93.43 79.21 88.98 Short Term Borrowings 1,054.24 810.88 765.58 409.27 371.69 454.21 525.10 473.83 392.85 124.97 Short Term Provisions 17.45 27.31 36.56 28.53 11.66 5.20 8.62 3.90 1.58 13.45 Total Liabilities 5,483.87 4,903.14 4,511.53 3,712.67 3,223.10 2,978.58 2,670.28 1,878.72 1,562.97 1,202.71 Net Block 2,095.62 1,910.92 1,541.17 1,332.00 1,203.97 944.25 776.73 644.34 559.94 616.55 Gross Block 3,351.81 2,981.22 2,461.77 2,145.15 1,875.23 1,472.94 1,199.63 983.66 822.98 843.76 Accumulated Depreciation 1,256.19 1,070.30 920.59 813.15 671.26 528.69 422.90 339.32 263.05 227.21 Non Current Assets 2,578.83 2,328.99 2,006.54 1,715.68 1,594.41 1,696.34 1,483.71 1,050.55 744.97 699.69 Capital Work in Progress 271.70 239.39 356.23 239.08 294.20 495.95 514.52 267.43 76.56 62.03 Non Current Investment 21.52 21.21 19.67 18.99 19.34 210.42 156.56 108.23 70.11 0.19 Long Term Loans & Adv. 190.00 157.47 89.47 125.61 76.89 45.72 35.91 30.56 38.37 20.76 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 Current Assets 2,905.05 2,574.15 2,504.99 1,997.00 1,628.70 1,282.24 1,186.57 828.16 818.00 500.36 Current Investments 0.00 0.00 0.00 0.00 109.85 0.00 0.00 0.00 0.00 0.00 Inventories 1,300.55 1,149.41 978.55 782.18 438.43 384.21 279.95 269.18 253.72 224.52 Sundry Debtors 985.83 948.54 924.95 765.42 662.04 673.54 628.25 417.70 375.35 136.91 Cash & Bank 386.38 312.79 409.46 271.04 283.94 89.04 115.64 49.80 130.29 65.31 Other Current Assets 232.28 49.22 61.67 50.74 134.43 135.45 162.73 91.49 58.65 73.63 Short Term Loans & Adv. 186.00 114.19 130.35 127.61 91.83 98.46 114.09 51.66 48.68 2.05 Net Current Assets 822.75 760.65 863.38 823.90 735.30 385.76 308.65 41.03 163.25 85.33 Total Assets 5,483.88 4,903.14 4,511.53 3,712.68 3,223.11 2,978.58 2,670.28 1,878.71 1,562.97 1,202.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 316.93 663.68 280.29 374.66 494.79 226.85 23.98 190.14 143.98 134.98 PBT 591.29 663.94 519.65 732.87 553.03 241.71 208.45 206.80 180.96 132.26 Adjustment 229.36 178.19 137.11 153.72 -53.91 121.92 91.94 94.81 90.88 80.91 Changes in Working Capital -346.65 -1.30 -233.77 -325.99 115.30 -49.97 -222.92 -52.64 -80.27 -46.95 Cash after chg. in Working capital 474.00 840.82 422.99 560.60 614.42 313.66 77.47 248.97 191.57 166.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -157.07 -177.14 -142.70 -185.94 -119.63 -86.80 -53.49 -58.83 -47.59 -31.24 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -302.98 -96.45 -318.45 -232.62 -164.80 -242.91 -494.86 -299.57 -171.22 -130.28 Net Fixed Assets -101.04 -104.53 -302.61 -204.42 -124.57 -176.36 -282.01 -249.86 -75.62 -231.53 Net Investments -264.87 -80.00 -5.00 -36.29 -48.78 -431.34 -0.01 13.84 -16.48 72.98 Others 62.93 88.08 -10.84 8.09 8.55 364.79 -212.84 -63.55 -79.12 28.27 Cash from Financing Activity 26.14 -519.47 151.43 -296.21 -212.29 -17.33 528.75 36.23 85.70 24.87 Net Cash Inflow / Outflow 40.10 47.76 113.27 -154.17 117.70 -33.39 57.87 -73.20 58.47 29.56 Opening Cash & Equivalents 181.75 134.24 20.03 174.32 56.42 89.81 31.94 104.76 52.23 22.67 Closing Cash & Equivalent 223.08 181.75 134.24 20.03 174.32 56.42 89.81 31.94 110.70 52.23

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 439.41 738.75 332.06 432.48 476.19 262.24 -0.65 188.24 151.43 150.28 PBT 547.23 687.17 558.00 704.36 425.64 276.78 180.00 204.99 186.03 127.96 Adjustment 328.80 237.69 176.29 194.43 156.88 149.85 107.45 95.14 92.63 85.37 Changes in Working Capital -246.32 -10.31 -257.19 -274.95 12.75 -75.94 -230.03 -52.37 -79.70 -31.34 Cash after chg. in Working capital 629.71 914.55 477.11 623.84 595.27 350.69 57.42 247.77 198.97 182.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -190.30 -175.80 -145.05 -191.37 -119.08 -88.45 -58.07 -59.53 -47.54 -31.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -360.16 -191.36 -380.12 -277.13 -160.63 -269.82 -462.31 -326.09 -161.65 -145.55 Net Fixed Assets -101.04 -104.53 -302.61 -204.42 -124.57 -176.36 -282.01 -249.86 -75.62 -231.53 Net Investments -264.87 -80.00 -5.00 -36.29 -48.78 -431.34 -0.01 13.84 -16.48 72.98 Others 5.75 -6.83 -72.51 -36.42 12.72 337.88 -180.29 -90.07 -69.55 13.00 Cash from Financing Activity 7.66 -440.29 190.00 -299.31 -212.85 -17.43 528.62 55.87 85.67 18.83 Net Cash Inflow / Outflow 86.92 107.10 141.94 -143.97 102.70 -25.01 65.66 -81.98 75.44 23.56 Opening Cash & Equivalents 291.56 184.71 41.84 185.93 83.02 108.03 42.37 124.35 54.85 41.75 Closing Cash & Equivalent 381.10 291.56 184.71 41.84 185.93 83.02 108.03 42.37 130.29 65.31

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 127.79 110.97 101.55 86.90 70.91 55.71 50.14 38.56 29.33 20.75 ROA 9.17% 11.24% 9.60% 16.19% 14.88% 5.92% 6.19% 8.35% 9.03% 9.73% ROE 15.08% 19.17% 16.55% 27.95% 27.59% 12.04% 12.92% 18.82% 22.80% 24.88% ROCE 17.06% 19.55% 16.29% 26.53% 22.67% 11.56% 12.71% 16.79% 20.36% 21.63% Fixed Asset Turnover 1.66 1.89 1.78 1.98 1.71 1.87 1.65 1.60 1.79 2.08 Receivable days 146.06 119.89 125.37 93.87 104.53 120.48 128.14 121.18 86.06 45.56 Inventory Days 56.96 54.97 59.31 46.08 51.67 46.70 51.31 59.46 52.52 43.81 Payable days 133.89 114.09 115.71 100.40 57.71 53.12 62.58 65.51 60.24 56.59 Cash Conversion Cycle 69.13 60.78 68.97 39.55 98.49 114.06 116.87 115.13 78.34 32.79 Total Debt/Equity 0.34 0.34 0.42 0.39 0.49 0.70 0.77 0.74 1.01 0.98 Interest Cover 9.21 18.17 32.78 31.83 21.59 9.52 7.33 7.43 5.88 5.28

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 132.33 116.38 103.62 86.85 71.80 59.73 51.17 39.40 29.20 20.98 ROA 7.80% 10.97% 10.04% 15.84% 9.99% 6.64% 5.13% 8.12% 9.03% 8.31% ROE 13.46% 19.18% 17.49% 27.64% 18.54% 13.32% 10.60% 18.23% 23.53% 23.29% ROCE 15.66% 19.63% 17.37% 25.42% 17.22% 12.71% 11.09% 16.57% 20.16% 18.75% Fixed Asset Turnover 1.42 1.66 1.63 1.97 1.75 1.78 1.55 1.59 1.66 1.77 Receivable days 78.34 75.78 81.94 65.94 83.34 100.03 112.83 100.84 67.60 33.47 Inventory Days 99.22 86.07 85.35 56.39 51.34 51.03 59.23 66.49 63.11 54.79 Payable days 138.29 112.38 114.29 117.79 58.20 54.96 62.37 64.87 59.99 53.57 Cash Conversion Cycle 39.26 49.48 52.99 4.54 76.48 96.10 109.70 102.46 70.72 34.69 Total Debt/Equity 0.38 0.38 0.43 0.39 0.49 0.65 0.75 0.73 1.01 1.14 Interest Cover 6.17 13.29 25.04 27.80 16.75 10.72 6.44 7.36 6.02 4.96

Top Investors:

life insurance corporation of india

axis mutual fund trustee ltd. a/c axis mutual fund

fidelity funds - india focus fund

schroder international selection fund global emerg

ab sicav i - international health care portfolio

basava sankararao kolli

aditya birla sun life trustee private limited a/c

investor education and protection fund (iepf)

Annual Reports:

News Update:

Granules India's arm gets USFDA’s nod for Lisdexamfetamine dimesylate chewable tablets
17th Dec 2024, 12:30 PM

The approved drug is available in multiple strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg
Read More
Granules India gets OAI classification from USFDA for Hyderabad facility
3rd Dec 2024, 15:51 PM

Earlier, the USFDA had issued Form 483 with 6 observations for said facility
Read More
Granules India secures approval from SBTi for near-term, long-term, net-zero goals
27th Nov 2024, 15:13 PM

Granules’ goals are notable for their comprehensive scope and ambition
Read More
Granules India receives Golden Peacock Award for sustainability
14th Nov 2024, 16:55 PM

This recognition follows a highly competitive selection process with 499 applicants and a rigorous three-tier assessment
Read More
Granules India secures ANDA approval for Bupropion Hydrochloride Extended-Release Tablets
18th Oct 2024, 14:59 PM

Granules now has a total of 67 ANDA approvals from the USFDA
Read More
Granules India unveils mobile cancer screening unit at AIG Hospitals
24th Sep 2024, 14:39 PM

The state-of-the-art mobile unit ‘Breast Health Express,’ brings advanced medical technology directly to communities in need
Read More

Granules India Ltd.

Pharmaceuticals & Drugs - API

BSE: 532482 | NSE: GRANULES

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Granules India Ltd.

Pharmaceuticals & Drugs - API

BSE: 532482 | NSE: GRANULES

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: